- Home
- CFFI vs CATX Comparison
CFFI vs CATX Comparison
Compare CFFI & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFI
- CATX
- Stock Information
- Founded
- CFFI 1927
- CATX 1983
- Country
- CFFI United States
- CATX United States
- Employees
- CFFI N/A
- CATX N/A
- Industry
- CFFI Major Banks
- CATX Medical/Dental Instruments
- Sector
- CFFI Finance
- CATX Health Care
- Exchange
- CFFI Nasdaq
- CATX Nasdaq
- Market Cap
- CFFI 218.0M
- CATX 239.0M
- IPO Year
- CFFI 1998
- CATX N/A
- Fundamental
- Price
- CFFI $67.65
- CATX $3.66
- Analyst Decision
- CFFI
- CATX Strong Buy
- Analyst Count
- CFFI 0
- CATX 10
- Target Price
- CFFI N/A
- CATX $12.90
- AVG Volume (30 Days)
- CFFI 5.7K
- CATX 790.0K
- Earning Date
- CFFI 10-28-2025
- CATX 11-11-2025
- Dividend Yield
- CFFI 2.72%
- CATX N/A
- EPS Growth
- CFFI 32.15
- CATX N/A
- EPS
- CFFI 7.56
- CATX N/A
- Revenue
- CFFI $122,075,000.00
- CATX $1,235,000.00
- Revenue This Year
- CFFI N/A
- CATX N/A
- Revenue Next Year
- CFFI N/A
- CATX N/A
- P/E Ratio
- CFFI $8.95
- CATX N/A
- Revenue Growth
- CFFI 7.42
- CATX N/A
- 52 Week Low
- CFFI $53.14
- CATX $1.60
- 52 Week High
- CFFI $89.90
- CATX $13.56
- Technical
- Relative Strength Index (RSI)
- CFFI 45.23
- CATX 57.90
- Support Level
- CFFI $65.50
- CATX $3.33
- Resistance Level
- CFFI $69.58
- CATX $3.58
- Average True Range (ATR)
- CFFI 1.56
- CATX 0.23
- MACD
- CFFI -0.45
- CATX 0.05
- Stochastic Oscillator
- CFFI 34.19
- CATX 84.21
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.